Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atlanstat
Nantes, France
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Atlanstat is a French Contract Research Organization (CRO) that provides specialized services in biostatistics, data management, and clinical trial operations. Established in 2001, the company supports the pharmaceutical, biotechnology, and medical device industries through all phases of clinical development, from Phase I to Phase IV. Their core competencies include protocol optimization, electronic case report form (eCRF) design, and comprehensive statistical analysis. In February 2022, Atlanstat was acquired by Excelya, a major European CRO, to further strengthen the group's expertise in data sciences and clinical research services.
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on Atlanstat.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atlanstat.